Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-032254

Exec. VP Chief Legal Officer sold 37,884 shares at $10.22 ($387,125)

  • Exec. VP Chief Legal Officer acquired 37,884 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stark David Matthew Exec. VP Chief Legal Officer 2021-05-11 Option exercise +37,884 40,858.39 D: show line 1 in the form
Stark David Matthew Exec. VP Chief Legal Officer 2021-05-11 Sale −37,884 $10.22 $387,125 2,974.39 D: show line 2 in the form
Open-market sales · 37,884 sh · avg $10.22 · $387,125

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stark David Matthew Exec. VP Chief Legal Officer 2021-05-11 Option exercise · Restricted Share Units −37,884 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…